Replies to post #203057 on Cytodyn Inc (CYDY)

[moneycrew]

I'll take number one or the first one listed for 100 dollars.
If you consider all that is going on, blend it up= partnership.

[Midnight-Rider]

B52....my vote is for partnership on one indication...

[Chuckles759]

I think the new management subscribes to a philosophy much different than when NP was in charge.

No half-baked PRs or CCs. No "potential" or "promising" results.

I think they'll tell us with past tense verbs that demonstrate they are action and accomplishment oriented.

I hate to say it....but I have NFI when the silence will end. I just know it is deafening.

[LABZ]

NEGOTIATIONS FOR A PARTNERSHIP ?!!

I also strongly believe that Negotiations are ongoing for a Partnership.

Look......we are close to results for both NASH 700mg trials & for
some preliminary information on the Brazil Covid-19 Trials.......
GOOD RESULTS, FOR EITHER, IS AN IMMEDIATE GAME CHANGER
FOR CYDY !!........and lays the foundation for substance discussions
for a Partnership.

I don't believe its a coincidence that Dr. B. Rae comes back in Nov, 2021 !!
Who do you know goes back to a specific job or company....unless your name
is Steve Job !! You would go back for SOMETHING BIG...A GAME CHANGER !!
The BOD had to weigh in and agree to bring Dr. Rae back !!!

CYDY states:
He has led negotiations and closed transactions in the US, Europe and
Japan and has experience working in the Chinese pharmaceutical market.

Dr. Kelly has been dropping bread crumbs & hints numerous times
last year on partnership discussions having viability.

SF A ........IN POST # 203066 ......SAYS IT ALL
From 12/14/2021 webcast:

(Dr. Kelly) “I would like to mention, I just recently presented at the World antiviral conference on November 30th. we covered a lot of ground in that. HIV mono, HIV prep, HIV cure project, combo therapy, covid 19 critical, LH, NASH and oncology and I think there is a growing interest in Leronlimab as a platform molecule across multiple indications and I think what that is going to do for us is that in terms of partnerships, we just brought back DR. BRANDON RAE worked with us in the past and now that we have data, Brandon is an attorney with virology experience and we are going to be looking at partnership opportunities not only with domestic, but also CHINA, Argentina, Taiwan, South East Asia, Mexico, Turkey, Korea. We are looking at multiple different things like ONCOLOGY, HIV, NAFLD, NASH, so I think it's really exciting where we are going into this new year.”

IS IT A COINCIDENCE THAT NP LEAVES THE COMPANY 1-1/2 MONTHS LATER ??!!

CLEAR THE DECKS FOR ANY POSSIBLE OPPOSITION......ADD NEW BOARD MEMBERS
AND SENIOR TEAM MEMBERS TO FACILITATE A PARTNERSHIP.....

[C-20]

B52T38- I honestly have no idea at this point. I’m not sure anyone does. Just like none of us knew NP was getting the boot. I would like to make a comment about the entire NP situation . He was the CEO right or wrong some of the blame sits squarely on his shoulders im glad he is gone. I also believe the FDA is not who many of us thought they were, in my very humble opinion they are bought and paid for by big Parma. I think NP made it easy for them to attack us without showing there true intentions. Credibility is very important in everything we do and when you lose that you have lost everything. I believe in LL and getting any new drug to approval is difficult unless you are big pharma . I’m convinced we need a big pharma connection in some capacity , probably a buyout or partnership to get this drug approved. If LL is owned by big pharma it will be approved within months if not sooner. Should be interesting and i will definitely be here to find out. Good luck ladies and gentlemen and may God bless you all no matter what side you stand on ,we all need that.